Core Viewpoint - The white paper released by the Chinese government emphasizes China's commitment to scientific virus tracing and international cooperation in combating the COVID-19 pandemic, while opposing the politicization of public health issues [1][2]. Group 1: China's Contributions to Pandemic Response - China has mobilized nationwide efforts to successfully navigate the pandemic, showcasing its capability as a large population country to overcome such a global crisis [1]. - The country has provided significant support to global pandemic control efforts, sharing knowledge and resources to fulfill its international responsibilities [1]. Group 2: Virus Tracing Efforts - China has actively engaged in scientific virus tracing, collaborating with the World Health Organization (WHO) and conducting multiple key studies in 2020 and 2021 [2]. - The joint research report published by WHO and Chinese experts has been widely recognized for its rigorous and scientific conclusions, which indicate that Wuhan is not the natural origin of the virus [2]. Group 3: Political Dynamics and Global Health - Research indicates that the virus likely originated outside of China, with evidence suggesting earlier positive cases in the U.S. than in Wuhan [3]. - The U.S. government's failure to address its own pandemic response and its tendency to blame China for the outbreak has hindered global virus tracing efforts and public health system development [3].

Core Viewpoint - The Chinese government emphasizes the need for further investigation into the origins of COVID-19, particularly focusing on the United States, citing evidence that the virus may have existed in the U.S. before the first reported cases [1][2][3] Group 1: China's Actions and Position - China has invested significant resources in collaboration with international scientists for COVID-19 virus tracing research, maintaining an open and transparent approach [1] - The country has conducted various epidemiological studies and invited WHO experts to China for joint research in 2020 and 2021 [1] - As of now, there is no evidence contradicting the conclusions of the WHO report on the virus's origins published in March 2021 [1] Group 2: Evidence from the United States - Research indicates that COVID-19 may have originated outside of China, with studies showing positive antibody samples in the U.S. as early as December 2019 [2] - The U.S. National Institutes of Health's "All of Us" project found COVID-19 antibodies in blood samples collected from January 2 to March 18, 2020, suggesting early low-level transmission in the U.S. [2] - Experts from The Lancet suggest that the virus may not have a natural origin but could be linked to a laboratory accident in the U.S., citing numerous laboratory incidents involving dangerous pathogens [2] Group 3: Call for U.S. Accountability - The Chinese official calls for a comprehensive investigation into the early COVID-19 cases in the U.S., asserting that the timeline of the outbreak in the U.S. predates official reports [3] - The U.S. is urged to respond to international concerns and share early suspected case data with the WHO for accountability [3]

Core Viewpoint - The Chinese Ministry of Foreign Affairs asserts that the conclusion of "laboratory leak is extremely unlikely" regarding the origin of the COVID-19 virus is a scientifically authoritative conclusion recognized by the international community and scientific circles [1] Summary by Relevant Sections - **Position on Virus Origin** - The Chinese government has reiterated its stance on the origin tracing of the COVID-19 virus, emphasizing that it is a scientific issue that should be judged by scientists [1] - **Scientific Basis for Conclusion** - The conclusion that a laboratory leak is extremely unlikely is based on expert visits to relevant laboratories and in-depth discussions with researchers, which has led to broad recognition within the international scientific community [1]

国家卫生健康委有关负责人就白皮书发布答记者问。 下一步的溯源工作应该重点在美国开展。大量研究表明，新冠病毒起源于中国境外。 美国疾控 中心研究论文显示，2019年12月13日至2020年1月17日采集自9个州的7389份血清学调查样本中发现了106份新冠病毒抗体阳性样本，显示新冠病毒可 能早在美国首例病例发现前就已存在于美国。美国国立卫生研究院发起的"All of Us"项目分析了2020年1月2日至3月18日期间参与项目50个州的 24079份血液样本，在9份样本中检测到了新冠抗体。最早的阳性样本分别来自1月7日和1月8日。研究结果表明新冠病毒早在2019年12月就在美国各 地以低水平传播，比第一批正式报告病例明显提前。《柳叶刀》杂志专家表示，新冠病毒或许并非来自自然，而可能来源于美国生物技术实验室的 一次意外事故。2006年到2013年期间，全美国的实验室里，至少发生过1500起严重的实验室事故，涉及严重急性呼吸综合征、中东呼吸综合征、埃 博拉、炭疽、天花、禽流感、冠状病毒等危害极大的病原体。 这诸多疑点均提示美国新冠疫情发生的时间早于其官方公布时间，也早于中国新冠疫情暴发时间，应该对美国开展全面深入的新 ...

Group 1 - The white paper outlines China's proactive role in COVID-19 virus tracing and its contributions to global pandemic response, emphasizing transparency and cooperation with the World Health Organization [2][4][12] - China has conducted extensive research in key areas such as clinical epidemiology and molecular epidemiology, collaborating closely with international experts to trace the origins of the virus [5][6][8] - The findings from China's tracing efforts indicate that the virus likely did not originate in Wuhan, with extensive studies showing no evidence of the virus in local wildlife or early human cases prior to December 2019 [9][11][37] Group 2 - China has shared critical pandemic information and virus genome sequences with the international community, establishing a robust information dissemination system to prevent misinformation [13][14][15] - The country has provided significant support to global pandemic efforts, including sending medical teams and supplies to over 150 countries, and has committed to supplying vaccines as a global public good [17][19][20] - China's approach to pandemic response has been characterized by a commitment to international cooperation and the establishment of a global health governance framework [20][21] Group 3 - The white paper criticizes the United States for its inadequate response to the pandemic, highlighting failures in timely action and the politicization of virus tracing [22][24][30] - It points out that the U.S. has attempted to shift blame onto China, undermining international cooperation and public health efforts [30][28] - The document also notes that evidence suggests the virus may have originated outside of China, with early cases detected in the U.S. prior to the official outbreak [37][38]

Core Viewpoint - The white paper released by the State Council Information Office emphasizes the need for a comprehensive investigation into the origins of COVID-19, particularly focusing on the United States, as research indicates the virus originated outside of China [1] Group 1: Origin Investigation - The next phase of virus tracing should primarily target the United States, as numerous studies suggest that the COVID-19 outbreak in the U.S. occurred earlier than officially reported [1] - There are multiple indications that the onset of the COVID-19 pandemic in the U.S. predates the timeline provided by U.S. authorities, as well as the outbreak in China [1] Group 2: International Cooperation - The U.S. is urged to respond to international concerns and share early suspected case data with the World Health Organization to provide a responsible account to the global community [1]

Group 1 - The white paper emphasizes China's commitment to contributing wisdom and resources for the tracing of the COVID-19 virus, highlighting its proactive role in international cooperation and transparency in research efforts [1][2] - China has conducted extensive research in key areas such as clinical epidemiology, molecular epidemiology, environmental epidemiology, and animal host tracking, demonstrating a high level of responsibility and transparency in supporting the World Health Organization's joint tracing studies [1] - The white paper asserts that studies conducted under the WHO's guidance have ruled out Wuhan as the natural origin of the virus and deemed the lab leak theory as highly unlikely, providing critical empirical data for the global scientific community [1] Group 2 - The document outlines China's efforts to share information and resources with the international community, including sharing virus gene sequences and inviting WHO experts for collaborative tracing efforts [2] - It criticizes the United States for politicizing the virus tracing process and failing to reflect on its own pandemic response, suggesting that the U.S. should conduct a thorough investigation into the origins of the virus [2] - The white paper reiterates that infectious diseases are a common enemy of humanity and warns against politicizing scientific actions, emphasizing China's commitment to global public health development and governance [2]

Group 1 - The article emphasizes that the recent claims by the U.S. regarding the origin of the COVID-19 virus being linked to a laboratory leak in Wuhan lack scientific basis and are considered fabricated [1] - It highlights that the U.S. has repeatedly attempted to politicize the scientific issue of the virus's origin, which has been met with skepticism from the scientific community [1] - The article suggests that evidence increasingly points to the virus having appeared earlier in the U.S., calling for further investigation into the origins of the virus within the U.S. [1] Group 2 - The article urges the U.S. to cease its smear campaigns against China and to address its own issues regarding the pandemic [1] - It calls for accountability from the U.S. to the global community regarding the handling of the COVID-19 situation [1]

美方反复在新冠病毒起源问题上对中国栽赃抹黑，充分暴露了美方将科学问题政治化的险恶嘴脸，科 学界早已嗤之以鼻。美方妄图以疫遏华制华，其阴谋绝不会得逞。 目前，越来越多的线索和证据指向新冠病毒更早出现在美国，下一步溯源工作应在美国展开。我们敦 促美方，立即停止对华抹黑攻击，正视自身的问题，给全世界人民和国际社会一个认真负责的交代。 据新华社，4月23日，国家卫生健康委新闻发言人表示，近日美国白宫网站发布题为《实验室泄漏： 新冠病毒的真正起源》的文章，与之前美方多次翻炒新冠病毒"武汉实验室泄漏"一样，所谓的"理 由"毫无科学依据，所谓的"证据"完全是胡编乱造。 ...